SARS-CoV-2 | European Cystic Fibrosis Society (ECFS)

Are there long-term consequences of the SARS-CoV-2 infection in people with CF? Results of a prospective study with a specific focus on long COVID

Analysis of cell mechanisms influencing Covid-19 disease in cystic fibrosis patients and in the general population

Immune response after COVID-19 vaccination in cystic fibrosis patients

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.

The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis

SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis

A multinational report to characterise SARs-CoV-2 infection in people with cystic fibrosis